Cross Disciplinary Collaboration a Driver of Scientific Innovation
Involving more than 15 different universities, the CONP aims to bring together leading Canadian scientists to form an interactive network of collaborations in brain research.
TOPICS Research on the brain, especially the effects and causes of Alzheimer’s, has been a primary focus for Canadian scientists. Follow their path and stay up to date on their findings.
Involving more than 15 different universities, the CONP aims to bring together leading Canadian scientists to form an interactive network of collaborations in brain research.
As an innovation accelerator, CABHI is at the forefront of getting innovations and technologies into the hands of dementia patients and their families.
How can you enrich life with dementia? Ask Paul Lea, a dementia advocate who was diagnosed with vascular dementia in 2009.
Biotech ProMIS Neurosciences is researching a new drug candidate that targets the root causes of neurodegenerative diseases like Alzheimer's.
Global leaders will present the latest news in dementia prevention at the Rotman Research Institute's annual conference on aging & brain health.
The biotech company KalGene Pharmaceuticals is developing a unique Alzheimer's disease therapeutic agent, using biomarkers and translational imaging.